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Introduction
Epidural analgesia remains the best technique to
provide pain relief during labor and combination with
analgesic adjuvants is recommended to spare local anes-
thetic consumption. Available analgesic adjuvants
involve opioids, clonidine and the cholinesterase
inhibitor, neostigmine (N). In contrast with opioids and
clonidine which have both demonstrated a significant
local anesthetic sparing effect, epidural N administered
as a bolus dose of 5-7 µg/kg at the beginning of labor
(Roelants et al., Anesthesiology 2005) or as a continuous
infusion of 120 µg/h (Ross et al., Anesthesiology 2006 ;
104: A-33) failed to reduce local anesthetic require-
ments. Because underlying mechanisms of action differ
between these adjuvants, the formers being direct recep-
tor agonists while the later (N) acts as an indirect agonist
to increase locally spinal acetylcholine levels, the present
study assessed the way of epidural neostigmine adminis-
tration on ropivacaine (R ) needs during labor analgesia.
Methods
After Ethical Committee approval and informed
consent, healthy parturients (singleton pregnancy, term
> 37 weeks) in active labor and asking for epidural anal-
gesia were included. After lumbar epidural catheter
placement and negative test dose (3 mL lidocaine 2%
with epinephrine), the parturients (n = 20 per group)
were randomly allocated to receive analgesia by either
continuous infusion (CI) or PCEA device :
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CI R CI RN PCEA R PCEA RN
Bolus dose R 0.1% 10 mL R 0.1% 10 mL
with N 500 µg
R 0.1% 10 mL R 0.1% 10 mL
Epidural analgesia R 0.1% 
at 10 mL/h
R 0.1% + N 12.5 µg/mL
at 10 mL/h
R 0.1% 
at 5 mL/15 min
R 0.1% + N 25 µg/mL at
5 mL/15 min
CI R CI RN PCEA R PCEA RN
Rescue doses (n) 2 (1-3) 2 (1-2) 2 (1-3) 2 (1.5-2.5)
First rescue dose:
VAS (0-10)
Cervical dilatation (cm)
Time elapsed (min)
5.7 ± 2
5.5 (4-6)
125 (101-172)
5.5 ± 1.9
5 (5-6)
117.5 (90-170)
7.4 ± 1.8 †
6 (4.5-7)
125 (90-165)
7.0 ± 1.4 †
5.5 (4-7)
120 (100-207)
Ropivacaine use (mg/ h) 19.6 ± 5 18.6 ± 4 18.3 ± 5 14.5 ± 4 *
Rescue analgesia was available at any time as epidural
bolus of 10 mL R 0.1% (if VAS < 6/10) or R 0.2%
(if VAS  6/10). Number and timing of rescue doses,
total R needs and labor duration as well as fetal and
maternal parameters were recorded. Statistical analysis
used ANOVA one way or Kruskal-Wallis test with
posthoc comparison, P < 0.05 was considered to be sig-
nificant.
Results
Demographic data (age, weight, parity, induced
labor, ocytocine use) and labor duration did not differ
between the groups. In PCEA RN, N use was 160 ±
52 µg/h while in CI RN, the rate was fixed at 125 µg/h.
Results are expressed as median (IQR) or mean ±
SD ; (*) P < 0.05 with CI R, CI RN and PCEA R groups ;
(†) P < 0.05 with CI RN group
Discussion
Epidural neostigmine administered by PCEA mode
and without an initial bolus dose affordes a significant
local anesthetic sparing effect during labor. The present
results correlate with previous observations in humans
concerning both the pharmacokinetic and pharmacody-
namic of spinal neostigmine : i.e. neostigmine, inde-
pendently of the dose administered, rapidely provokes
sustained plateau concentrations of acetylcholine in the
CSF, during 4-6 h after N injection (Shafer et al,
Anesthesiology 1998). Therefore, initiation of analgesia
with a significant N bolus dose (e.g. 500-750 µg) certain-
ly may prevent further analgesic effect from the follow-
ing doses. In contrast with intermittent bolus doses
(PCEA mode), continuous infusion might also yield to
the saturation of the mechanism of cholinesterase inhibi-
tion.
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Introduction
Two case reports of acute maternal hypoglycaemia
following combined spinal epidural analgesia (CSE) for
labour pain have been reported in the literature (1, 2).
One case report occurred in a diabetic patient. We recent-
ly encountered a similar case of hypoglycaemia in our
own practice. Hypoglycaemia most likely occurred as a
result of decreased stress hormone levels. Hypo-
glycaemia may be a cause of foetal distress when it
occurs after regional analgesia. The present prospective
study was therefore undertaken to evaluate the effects of
CSE on maternal glycaemia in healthy parturients.
Methods
Following institutional ethics committee approval,
50 ASA 1 and 2, singleton, vertex presenting pregnant
patients were recruited to participate in this prospective
un-blinded, single group trial. Standard obstetric para-
meters as well as obstetric, foetal and neonatal outcome
were recorded. Maternal glycaemia was measured using
venous blood collected 5 minutes before CSE and 15 and
30 minutes after spinal analgesic injection. The blood
was collected from an intravenous line used only for
blood sampling. Hypoglycaemia was defined as a
glycaemia of < 80 mg/dl and a decrease in maternal
glycaemia of > 20% of baseline. Hypoglycaemia was
treated with 3 g of glucose if glycaemia was less then
50 mg/dl or if the patient had symptoms of hypogly-
caemia.
Results
Maternal glycaemia remained stable in the study
population : baseline glycaemia levels were 88 ± 18, at
15’ it was 93 ± 14 and at 30’ it was 94 ± 16 mg/dl. In two
patients hypoglycaemia occurred based on our defini-
tion. Glycaemia decreased to 56 and 62 mg/dl. Both
these patients did not show any clinical signs of hypogly-
caemia and did not need intravenous glucose. In none of
the hypoglycaemic patients foetal distress was observed.
Obstetric and neonatal outcome was good.
Discussion and conclusion
Based on the results of this small, prospective, un-
blinded trial, in a healthy patient population in active
labour CSE does not lead to significant hypoglycaemia.
However lowered levels of glycaemia may be observed.
If unexpected foetal distress occurs after CSE analgesia
control of the plasma glucose concentration and glucose
substitution should be considered.
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Background and Goal of the Study
Clonidine (CL), an a2-adrenoreceptor agonist,
reduces perioperative myocardial ischemia in patients
undergoing surgery (1). In an isolated heart model,
administrated a2-adrenoreceptor agonists portect against
ischemia. We investigated to demonstrate that the bene-
ficial effect of Clonidine is due to a post-hypoxic vaso-
motricity improvement (2).
Materials and Methods
After animal ethic committee approval, 60 aorta
rings (3  20) from 15 different rats were studied accord-
ing to a validated methodology (3). Two aorta rings were
put into two Krebs solution baths where Clonidine 10-
4M was added (CL Group). Two other aorta rings
bathing in Krebs solution only (free from Clonidine)
were used as the control group (CTL Group). After
15 minutes, all baths were emptied and filled with Krebs
solution 3 times. Then 25 minutes of hypoxia (PpO2 <
10 mmHg) was applied, followed by 40 minutes of
reoxygenation (PpO2 > 400 mmHg). After hypoxia-
reoxygenation, we evaluated post-hypoxic vasoconstric-
tion by cumulative Phenylephrine (PE) concentrations
(10-10M – 10-4M). Post-hypoxic endothelium-depend-
ent and independent vasoldilatations were investigated
respectively by cumulative Acetylcholine and
Nitroprusside concentrations (10-10M – 10-4M) on pre-
contracted aorta with Phenylephrine 10-4M. The statisti-
cal analysis used GEE regression, p < 0,05 was consid-
ered as significant.
Results and Discussions
In CL group, post-hypoxic endothelium-dependent
vasodilatation and vasoconstriction were significantly
different from the CTL group (p < 0,002 and p < 0,018,
respectively fig. 1 and 2). When considering post-hypox-
ic endothelium-independent vasodilatation, no signifi-
cant difference was found.
Conclusion(s)
CL enhances post-hypoxic endothelium-dependent
vasodilatation and vasoconstriction, a phenomenon
involved in myocardial ischemic protection. Then
Clonidine could be used for ischemic protection in
patient at risk.
References
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Clonidine improves post-hypoxic vasomotricity of isolated rats aorta. B. BRÉE*, M. GOURDIN**,
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Fig. 1. — Dose response relationship of post hypoxic endothe-
lium-dependent vasodilatation.
Fig. 2. — Dose response relationship of post hypoxic vasocon-
striction with endothelium.
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Introduction
Postoperative pain is a serious problem, requiring
an appropriate response from the medical doctor. 
In Orthopedics special attention is needed after
knee surgery (1). Although Tramadol is available in dif-
ferent formulas (capsules, tablets, oral solutions, and
injectable solutions), a new form has been developed to
optimize and to simplify its use. The new formula is a
tablet (Tradonal odis®) with chemical structure provid-
ing faster absorption due it’s enhanced release (2). The
aim of the study is to compare this formula type of tra-
madol (Tradonal odis®) with the intravenous route
(Contramal®) for analgesia after knee surgery. 
Methods
After Ethical Committee approval and following
informed consent, 60 patients undergoing an elective
knee arthroscopy in the surgical day clinic, participated
to this open-label study, they were divided into 2 groups
(30 received one dose of 100 mg Tradonal odis ® tablet
and 30 received one dose of 100 mg IV (Contramal®)
postoperatively in the PACU. 
Both groups were premedicated with 0.5 mg alpra-
zolam po and the general anesthesia was standardized
with intravenous Sufenta®, propofol, ventilation with
O2/air (30/70%) through a laryngeal mask and sevoflu-
rane was used for maintenance anaesthesia. Peroperative
all Patients received 2g IV Perfusalgan® and 30 mg of IV
Taradyl®. Numerical Rating Scale (NRS) 1 to 10 was
used to evaluate postoperative pain, and also patient
satisfaction, adverse effects of the drugs were also
evaluated every ten minutes for the first hour after
administration of the study medication, then after an
hour postoperatively. 
The patient was received extra opioids (IV piritra-
mide), when pain relief proved to be insufficient 30 min-
utes after administration of the study medication. 
The Chi-Square Tests and t-test were used to evalu-
ate statistical relevancy. A value of p < 0.05 was consid-
ered as statistically significant.
Results
20 pateints were excluded from the study because
they did not match the preoperative standardized condi-
tions. In the participated patients the NRS revealed that
mild or absent pain(NRS < 4) was present in 18 out of 21
of patients that were treated with contramal®, and 10 out
of 19 of patients that were treated with Tradonal odis® (p
< 0.05). Furthermore, 9 out of 19 patients in the Tradonal
odis® group requested extra piritramide as opposed to 3
out of 21 in the Contramal® group (P = 0,02). The inci-
dence of nausea and vomiting was equal between the two
groups, nausea was present in 4 out of 21 patients that
were treated with contramal®, and 2 out of 19 patients
that were treated with Tradonal odis®.
The use of IV Tramadol (Contramal®) versus immediate release Tramadol (Tradonal odis® ) in the
postoperative period after knee surgery in a day surgery setting. R. DAKHEEL, M.D., A. TEUNKENS,
M.D., E. VANDERMEERSCH, M.D., Ph.D., Anesth. Dept., C. Huygens, anesthesia research nurse.
University Hospitals, Katholieke Universiteit Leuven, Herestraat 49, B-3000 Leuven, Belgium.
Table
NRS 30 minutes after administration of the study medication
TYPE TIME (minutes) Cases
NRS < 4 NRS  4 Total
N Percent N Percent N Percent
T Odis® 30 m 10 52,4% 9 47,6% 19 100,0%
Contramal® 30 m 18 85,7% 3 14,3% 21 100,0%
Discussion
The efficacy of intravenous tramadol (Contramal®)
has already been demonstrated in many trials investigat-
ing pain relief after knee surgery (3), there is however no
literature made to compare the efficacy of Tardonal
odis® in the postoperative setting with the IV
Contramal®. In this study we found that patients treated
with Contramal® had pain of lower intensity in the first
hour after administration compared to those treated with
Tradonal odis ®, and less patients required piritramide as
supplementary treatment. Furthermore, no significant
difference was found in the incidence of nausea and
vomiting between the two group.
Conclusion
We concluded that Contramal® is more effective
compared to Tradonal odis ® to treat immediate postop-
erative pain following knee surgery, and with the same
incidence of nausea and vomiting.
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Background
Closed-loop control of the hypnotic component of
anesthesia has been proposed in an attempt to optimize
drug delivery. Here, we introduce a newly developed
Bayesian-based, patient-individualized, model-based,
adaptive control method for BIS guided propofol infu-
sion into clinical practice and compare its accuracy and
clinical feasibility under direct observation of an anes-
thesiologist versus BIS guided, effect compartment con-
trolled propofol administration titrated by the anesthesi-
ologist during ambulatory gynecological procedures.
Methods
After Institutional Ethics Committee approval,
informed consent was obtained from 40 ASA I and II
female patients, aged 18-45 years. All patients were ran-
domly allocated to the closed-loop or manual control
group. All patients received midazolam 1 mg iv and
alfentanil 0.5 mg iv prior to induction. In the closed-loop
control group, propofol was administered using the pre-
viously described closed-loop control system (1, 2) to
reach and maintain a target BIS of 50. In the manual con-
trol group, the propofol effect-site concentration was
adapted at the discretion of the anesthesiologist to reach
and maintain a BIS as close as possible to 50. Induction
characteristics, performance and robustness during main-
tenance and recovery times were compared. Hemo-
dynamic and respiratory stability were calculated as
clinical feasibility parameters. Statistical analysis was
performed using SPSS. All data were checked for
Gaussian distribution by the method of Kolmogorov and
Smirnov. Differences between groups were analyzed by
a Student-T-test or Mann-Withney test, depending on
their distribution. Categorical data (movement) were
analyzed by a Chi-squared test.
Results
The closed-loop control system titrated propofol
administration accurately resulting in BIS values close to
the set point (figure, * = p < 0.05 between groups). The
closed-loop control system was able to induce the
patients within clinically accepted time limits and with
less overshoot than the manual control group (Induction
time (s) 66 ± 25 versus 49 ± 9 ; BISpeak 40 ± 7 versus 33±
10, P < 0.05). Automated control resulted in beneficial
recovery times (time between stop propofol and opening
eyes (s) 215 ± 133 versus 316 ± 125, P < 0.05). Our
closed-loop control group showed similar acceptable
clinical performance specified by similar hemodynamic,
respiratory stability, comparable movement rates and
quality scores than the manual control group.
Accuracy and clinical feasibility of a new Bayesian-based closed-loop control system for propofol
administration using the BIS as a controlled variable. Bjorn E. K. HEYSE, M.D., Tom DE SMET,
M.Sc., Martine M. NECKEBROEK, M.D., Kristof VAN DEN HAUWE, M.D., Sjoert BONTE, B.Sc., Eric
P. MORTIER, M.D., D.Sc., Michel M. R. F. STRUYS, M.D., Ph.D. Department of Anesthesia, Ghent
University Hospital, De Pintelaan 185, 9000 Gent, Belgium.
Conclusions
The Bayesian-based closed loop control system for
propofol administration using the BIS as a controlled
variable performed accurate during anesthesia for ambu-
latory gynecological procedures. This control system is
clinical feasible and can be further validated in clinical
practice.
References
1. De Smet T., Struys M. M. R. F., Greenwald S.,
Mortier E. P., Shafer S. L., Estimation of optimal
modeling weights for a Bayesian-based closed loop
system for propofol administration using the BIS as a
controlled variable : A simulation study, ANESTH.
ANALG., 105, 1629-38, 2007.
2. Struys M. M., De Smet T., Versichelen L. F., Van De
Velde S., Van den Broecke R., Mortier E. P., Compa-
rison of closed-loop controlled administration of
propofol using Bispectral Index as the controlled
variable versus “standard practice” controlled
administration, ANESTHESIOLOGY, 95, 6-17, 2001.
© Acta Anæsthesiologica Belgica, 2008, 59, n° 2
P.112
Background
The incidence of epidural haematoma is a very rare
phenomenon (1/168 000) complication of epidural
anaesthesia (1). It is usually associated with an altered
coagulopathy profile. Guidelines recommend coagula-
tion tests on an individual basis, according to history and
physical examination (2). But many anaesthesiologists
opt for systematic coagulation screening before perform-
ing an epidural analgesia out of fear of a neurologic com-
plication. 
Studies have demonstrated that such a policy is use-
less in general surgical procedures (3). 
The aim of this study was evaluate the usefulness of
such a systematic coagulation screening in obstetric
anaesthesia. 
Methods
In this retrospective study, we have reviewed the
charts of 1500 women who delivered between September
2005 and April 2007 and in whom coagulation had been
screened during the last month of pregnancy. 
Results
A platelet count was performed in 1101 patients.
All of them were > 100 000/mm3. PT and APTT or TCA
were performed in 996 patients. Only 3 patients present-
ed abnormalities for these tests. In one patient the PT
was 69% and this patient received an uneventful epidur-
al analgesia. In the second patient, the APTT was 40 sec.
The patient underwent a caesarean section under general
anaesthesia for eclampsia. Postoperative evolution was
favourable and coagulation was normal at day 3. 
In a third patient the PT was 61% and the TCA
43.6 sec. These abnormalities were ignored. The patient
received an epidural analgesia for labour followed by an
uneventful caesarean section under epidural anaesthesia
for mechanical dystocia. 
No coagulation tests were performed during the
postpartum period. 
The three patients with coagulation abnormalities
presented a history suggesting possible coagulation dis-
order. 
Discussion
Among the 1500 patient records we reviewed,
3 patients had abnormal coagulation tests. In these
3 patients, a coagulation disorder would have been sus-
pected by an oriented questionnaire that would have
prompted the anaesthesiologist to order coagulation
tests. 
We conclude that coagulation disorders are rare and
can be suspected by a well designed questionnaire. 
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Introduction
The primary aim of this study was to compare the
preliminary results of a semi automated closed-loop
(SACL) TCI system allowing the anaesthesiologist to
build predefined algorithms to titrate simultaneously the
propofol and remifentanil effect site concentrations (Ce),
with a manually controlled effect site model.
The secondary aim was to investigate if the (SACL)
refocused the anaesthetist attention to patient care.
Material and Methods
After institutional review board approval and writ-
ten informed consent,eighteen patients undergoing
abdominal surgery lasting more than 2 hours were anaes-
thetized using the TOOLBOX System (1) with a SACL
proportional propofol and remifentanil effect-site Target
Controlled Infusion (eTCI). Propofol Ce was titrated
according to a predefined range of BIS or entropy values
using the population PK/PD set of Schnider (2).
Remifentanil Ce was based on a range of heart rate and
systolic blood pressure limits represented in a matrix
using the PK/PD set of Minto (3). For both drugs, mini-
mum and maximal Ce values which cannot be overtaken
by the SACL system were preprogrammed. The eTCI
induction phase was manually titrated by the anaesthetist
in charge of the patient and the SACL control was acti-
vated from the tracheal intubation until end of surgery.
During surgery, the anaesthetist could adapt the BIS or
Entropy and haemodynamic range values of the con-
troller and could change the proposed Ce limit targets of
the SACL pilot. At any time, the anaesthesiologist was
the final decider. The haemodynamic data and Ce target
concentrations were saved every 5 seconds. A group of
23 patients undergoing the same type of surgical proce-
dure and anaesthetized by the same team of anaesthetists
served as the control group. These patients were anaes-
thetized using remifentanil and propofol eTCI controlled
manually according to the EEG and haemodynamic
patients’ responses. Results were analyzed using a 2-
tailed Student t-test for continuous data after verification
for normal distribution otherwise the Mann-Whitney U
test was used. A p value < 0.05 was considered statisti-
cally significant. Data are reported as mean ± SD.
Analyses were performed using SPSS version 15.0
(SPSS Science Inc., Chicago IL).
Results
The Efficacy Of The Semi-Automated Closed-Loop propofol-remifentanil effect-site versus Manual
TCI Anaesthesia. F. KANDIL*, G. BEJJANI*, O. CAELEN**, G. BONTEMPI**, E. ENGELMAN*,
L. BARVAIS*. Erasmus Hospital Anaesthesia Department and **Machine Learning Group,
Computer Science, Free University of Brussels, Belgium.
* : p < 0.05 SACL Control Manual Control
Mean Propofol Ce (µg/ml) 2.4 ± 0.9 2.7 ± 0.8
N = Ce Propofol changes/hour 30.9* 2.3*
Mean Remifentanil Ce (ng/ml) 5.2 ± 2.4 6.1 ± 2.4
N = Ce Remifentanil changes/hour 18.5* 4.4*
% of time BIS in the range 40 to 60 68.5* 49.1*
% of time BIS less than 40 27.9* 43.4*
% of time BIS more than 70 3.6* 7.5*
Discussion
The number of interventions of the SACL controller
during the maintenance phase of anaesthesia is much
higher than the anaesthetist eTCI responsiveness as
measured by the number of target changes. The use of
such a SACL eTCI system decreases the number of
episodes of BIS or Entropy values out of the proposed
range (40-60) and the likelihood of BIS or Entropy val-
ues greater than 70 which could be associated with
awareness. The SACL eTCI system also shows a trend of
a decrease of the mean propofol and remifentanil Ce. In
conclusion, the combined use of semi-automated algo-
rithms of propofol Ce according to frontal EEG values
and remifentanil Ce according to a matrix of heart rate
and systolic blood pressure bound limits must be tested
in the future on a larger scale to evaluate its pharma-
coeconomic interest, its safety for the patient and its
acceptance by the anaesthetist.
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Introduction
Epidural analgesia remains the best technique to
provide pain relief during labor and the combination of
local anesthetic with analgesic adjuvant is recommended
to spare the local anesthetic consumption (Practice
guidelines, Anesthesiology 2007). Currently available
adjuvants involve lipophilic opioids, clonidine and the
cholinesterase inhibitor, neostigmine (N). Epidural opi-
oids and clonidine have both demonstrated reproducible
significant local anesthetic sparing effect (25-30%) dur-
ing labor analgesia. In contrast, N administered as a
bolus dose or as a continuous infusion failed to demon-
strate any local anesthetic sparing effect (Ross et al.,
Anesthesiology 2006, 104 : A33 ; Belhadj et al., ASA
2007 : A1774 ; Roelants et al., Anesthesiology 2005).
The underlying mechanisms of action differ between
these classes of adjuvants, opioid agonists and clonidine
being direct receptor agonists while N acts as an indirect
agonist which inhibits cholinesterase enzyme and there-
by increases locally spinal acetylcholine concentrations
(Shafer et al., Anesthesiology 1998). Taking that into
account, the present study evaluated analgesic efficacy
and eventual local anesthetic sparing effect of N added to
ropivacaine 0.1% and administered by patient-controlled
epidural analgesia (PCEA) without an initial bolus dose.
Methods
After Ethical Committee approval and informed
consent, healthy parturients (singleton pregnancy, term
> 37 weeks) in active labor and asking for epidural anal-
gesia were included. After lumbar epidural catheter
placement and negative test dose (3 mL lidocaine 2%
with epinephrine), all the parturients received a bolus
dose of 10 mL ropivacaine 0.1% before being allowed to
use a PCEA device set as a 5 mL bolus dose per 15 min,
with no background infusion. The parturients were ran-
domly allocated to the following groups according to the
analgesic solution : ropivacaine (R) 0.1% (R group, n =
20), ropivacaine 0.1% with sufentanil 0.5 µg/mL (RS
group, n = 21) and ropivacaine 0.1% with neostigmine
25 µg/mL (RN group, n = 19). Rescue analgesia was
available at any time as an epidural bolus of 10 mL R
0.1% (if VAS < 6/10) or R 0.2% (if VAS  6/10).
Number and timing of rescue doses, total ropivacaine
needs and labor duration were recorded. Fetal and mater-
nal parameters were continuously monitored and mater-
nal side effects were noted. Statistical analysis used
ANOVA one way or Kruskal-Wallis test with posthoc
comparison, P < 0.05 was considered to be significant.
Results
Demographic data (age, weight, parity, induced
labor, ocytocine use) and labor duration did not differ
between the groups. Results are expressed as median
(IQR) or mean ± SD ; (*) P < 0.05 with R group.
Epidural sufentanil use was 3.4 ± 2 µg/h and
neostigmine use was 160 ± 52 µg/h.
Ropivacaine sparing effect of epidural neostigmine administered for labor analgesia. V. LAMBEAUX,
F. ROELANTS, P. LAVAND’HOMME. Cliniques Universitaires St Luc, Université Catholique de Louvain,
Bruxelles.
R group RS group RN group
Rescue doses (n) 2 (1-3) 1 (1-2) 2 (1.5-2.5)
First rescue dose:
VAS (0-10)
Cervical dilatation (cm)
Time elapsed (min)
7.4 ± 1.8
6 (4.5-7)
125 (90-165)
6.3 ± 1.9
5.5 (4-9)
177 (110-230)
7.0 ± 1.5
5.5 (4-7)
120 (100-207)
Labor R use (mg/ h) 18.3 ± 5 13.6 ± 6 * 14.5 ± 4 *
Side effects : nausea (n)
Cesarean delivery (n)
1
2
1
4
4
2
Discussion
Epidural neostigmine administered by PCEA mode
and without an initial bolus dose affordes similar analge-
sia than epidural sufentanil and shows a significant local
anesthetic sparing effect during labor. The present results
correlate with previous observations in humans concern-
ing both the pharmacokinetic and pharmacodynamic of
spinal neostigmine : i.e. neostigmine, independently of
the dose administered, rapidely provokes sustained
plateau concentrations of acetylcholine in the CSF, dur-
ing 4-6 h after N injection (Shafer et al., Anesthesiology
1998). Therefore, initiation of analgesia with a signifi-
cant bolus dose of neostigmine (e.g. 500-750 µg) certain-
ly may prevent further analgesic effect from the follow-
ing doses. Continuous administration might also yield to
similar effect with a saturation of the mechanism of
cholinesterase inhibition.
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Background and Goal of the study
Severe perineal pain is a common problem after
vaginal delivery (1). Single dose epidural morphine
decreases postpartum use of oral pain medication (2).
Epidural neostigmine produces analgesia devoid of side
effects during labor (3). The study evaluates the benefit
of a single dose epidural neostigmine on postpartum pain
and analgesics requirements.
Material and Methods
After Institutional Ethical Committee approval and
Informed Consent, 41 healthy parturients (ASA 1&2,
singleton pregnancy) with epidural analgesia for labor
were included in the study. All parturients received
epidural ropivacaine combined with sufentanil during
labor. After delivery, patients were randomly allocated to
receive 5 mL saline (Group S ; n = 20) or neostigmine
500 µg in 5 mL saline (Group N ; n = 21). All parturients
were allowed to receive diclofenac (max 150 mg/d, with
oral paracetamol (max 3 g/d) at their discretion as rescue
analgesia. Postpartum pain scores (VAS : 0-10) and anal-
gesics consumption were recorded for 72 hours. Side
effects (nausea, vomiting and sedation) were recorded
until 2 hours after delivery. Pain and VAS score were
evaluated by phone call, at day 10. Statistical analysis
used one way ANOVA, P < 0.05 was considered signifi-
cant (*).
Results
Demographic data, including duration of first and
second stage of labor, neonatal weight, episiotomy, per-
ineal lacerations and instrumentation rate, did not differ
between both groups. Postpartum VAS were similar
between the groups during hospitalization (72 hours).
Results are expressed as median (IQR) or mean ± SD.
Efficacy of a single dose epidural neostigmine for postpartum pain. A. Pospiech, F. Roelants, AL
Richard, A. Payen, P. Lavand’homme. St Luc Hospital, Université Catholique de Louvain,
Brussels.
Group S
n = 20
Group N
n = 21
Diclofenac (mg) 325 (200-450) 300 (139-412)
Paracetamol J2
J3
Total (mg)
1500 (0-3000)
1000 (0-3000)
3500 (1000-9000)
750 (0-1000) *
5000 (0-1750) *
2500 (1000-5000)
Pain at day 10
VAS at day 10
41%
3.7 ± 1.9
30%
4.5 ± 2.3
Discussion and Conclusions
Single dose epidural neostigmine 500 µg adminis-
tered after delivery allowed a reduction of postpartum
paracetamol consumption, but did not affect pain scores
as previously observed with epidural morphine (1). In
contrast with epidural morphine administration which is
associated with nausea, pruritus and urinary retention,
epidural neostigmine administration was devoid of side
effects.
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Background and Goals
Acute back pain with sciatica (ABPWS) may origi-
nate form different causes (1). The effect on its relief by
invasive treatments like epidural injection with corticoids
is currently still controversial (2, 3). This retrospective
cohort study of patients treated with 80 mg Depo-
Medrol® and 3 ml Linisol 1%® for ABPWS tests the
hypothesis that pain relief after 3 weeks is more pro-
nounced if radiculopathy is the aetiologic factor. 
Material and Methods
Following institutional guidelines, 19 patients treat-
ed for ABPWS with an epidural injection were screened
for 3 weeks after the intervention. Examination and aeti-
ological investigations included MRI and/or CT imaging
results, pain drawing, and quadruple VAS scores for
pain. These VAS scores regarded pain experienced over
the past week : pain at its worst level (worse pain), at its
least intense level (lowest pain), pain at the moment of
the investigation, and average pain over the week. The
cohort was dichotomized in a subgroup ABPWS with
radiculopathy due to herniated intervertebral disc (n =
11) and a subgroup with ABPWS from other origins (n =
8). Non-parametric statistics were applied. A Wilcoxon
matched-pair ranked sign test was used on both the sub-
groups to test whether changes in VAS-score over time
were significant. This was followed by a Mann-Whitney-
U test to compare the VAS scores at the moment of
intake and three weeks later to test the hypothesis that the
epidural injection affected pain relief differently in these
two subgroups. Statistical significance was fixed at 0.05. 
Results
The 19 patients were clinically comparable. Patients
with a neuropathy restricted to just one dermatome
(radiculopathy) had better VAS scores over time.
Moreover, their most intense and lowest pain profile dif-
fered significantly from the other group. Data are shown
in figure 1.
Shortterm effect of lidocaine 1% and depo-medrol 80 mg administered epidurally for acute back pain
with sciatica. L. TEUGELS*, M.D., M. VERCAUTEREN**, M.D., Ph.D., D. HIMPE*, M.D., Ph.D. ZNA
Middelheim General Hospital (*) and University Hospital (**), Lindendreef 1, B-2020 Antwerp,
Belgium.
Fig. 1. — Visual Analog Pain scores (worse, average & lowest pain) at intake and
3 weeks after the epidural injection, presented as boxplots with median (line), box (25-
75 percentiles) and whiskers (95% CI). The radiculopathy group (white) had statistical-
ly significant (* p < 0.05) lower pain scores than the other group (grey).
Discussion and conclusion
Treatment of ABPWS with epidural steroids
should be scrutinized and preceded by thorough
investigation of its aetiology. From this study steroid
infiltration could be recommended in case of radiculo-
pathy. However, a cohort of only 19 patients might
be considered too small and therefore we suggest that
more conclusive investigations are required in larger
cohorts. 
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Introduction
Preeclampsia complicated with HELLP syndrome
leads to increased maternal and foetal morbidity and
mortality. The anaesthetic management is related to
maternal and/or foetal parameters. The goal of the pres-
ent retrospective chart analysis was to identify common
traits in HELLP patients presenting in our obstetric
department and describe the anaesthetic and obstetric
outcome.
Methods
Following institutional approval, the obstetric and
anaesthesia database was searched to identify patients
that were diagnosed with the HELLP syndrome between
Jan 1st 2000 and Dec 31st 2005. Obstetric and anaesthetic
parameters were gathered. Data were analysed using
Chi-square analysis and Student’s t-test whenever appro-
priate.
Results
We found that 108 out of 13580 patients were diag-
nosed with preeclampsia and HELLP (incidence 0.8%).
During the study period, 2912 patients were delivered by
caesarean section (CS) (21.4%). In the HELLP patients
the incidence of caesarean section was 78.7%. Vaginal
delivery was scheduled for 45 patients but failed in 22.
Gestational age at delivery was 31 weeks and 4 days.
Gestational age at the diagnosis of HELLP was on aver-
age 3.5 days earlier. Thrombocyte count was 54 ± 25 [9-
124]. Systolic and diastolic pressures were 180 ± 22 and
111 ± 12 mmHg respectively. De novo combined spinal
epidural anaesthesia (CSE) was used in 39 patients
undergoing caeserean section (46%), topped up epidural
anaesthesia was used in 22 patients (26%) and general
anaesthesia was used in 24 patients (28%). A higher inci-
dence of general anaesthesia was found in patients with
the HELLP syndrome compared to only 5% in the total
population undergoing caesarean section.
Discussion
The high incidence of HELLP is explained by the
referral function of our hospital. Delivery can usually be
postponed with 3-4 days. General anaesthesia occurs
frequently. Early epidural catheter placement must be
stimulated to maximize the use of regional anaesthesia
for delivery. 
Conclusion
To avoid general anaesthesia whenever possible,
early epidural catheter insertion is advised upon diagno-
sis.
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Characteristics, obstetric and anaesthetic outcome of the syndrome of Hemolysis, Elevated Liver
enzymes, Low Platelets (HELLP) in a tertiary referral center. Pascale WELTER, Frederik DE BUCK,
Eugéne VANDERMEERSCH, Marina KUYPERS, Marc VAN DE VELDE. Department of Anaesthesiology,
UZ Leuven, Belgium.
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Introduction
The incidence of postoperative nausea and vomiting (PONV)
is estimated to be 20 to 30%, but it may increase up to 70% in high
risk patients. Dexamethasone (DXM) and methylprednisolone
(MPS) have been proven effective in the prevention of nausea after
chemotherapy. Prophylaxis of PONV with dexamethasone is effec-
tive(1), while literature about methylprednisolone is scarce (2).
Methods
After approval of our institutional ethical committee we
therefore randomized 118 patients in a double blind way to receive
either DXM 8 mg (38 patients), MPS 40 mg (40 patients) or place-
bo (40 patients) as a prophylactic agent. Inclusion criteria were
female gender, adult age, elective abdominal or gynaecological
surgery and informed consent of all subjects. Exclusion criteria
were pregnancy or lactation, the intake of anti-emetic drugs within
24 hours preceding the surgery and emergency procedures. A stan-
dardized general anaesthesia regimen was performed. If normally
distributed, results of continuous data were expressed as means
(with SDs) and analyzed with Student’s t test. Variables that did not
show normal distribution were expressed as medians (with
interquartile ranges) and compared with the Mann-Whitney U test.
Categorical data were analyzedwith Fisher’s exact test. P values of
< 0.05 were considered statistically significant.
Results
There were no significant differences between our 3 groups
with regard to age, type of surgery, body mass index (BMI), histo-
ry of PONV, smoking status, use of N2O or use of clonidine.
Comparing methylprednisolone to dexamethasone-treatments for PONV : a prospective, randomised,
double-blind, placebo-controlled trial. M. WEREN*, M.D., J. L. DEMEERE**, M.D.,
E. VANDERMEERSCH*, M.D., Ph.D. *UZ Gasthuisberg, Herestraat 49, 3000 Leuven ; **Kliniek Sint-
Jan, Kruidtuinlaan 32, 1000 Brussels.
Table I
Incidence of PONV
DXM
(n = 38)
MPS
(n = 40)
Placebo
(n = 40)
p value MPS
vs. placebo
p value MPS
vs. DXM
Early nausea 7 (18, 8-34) 4 (10, 3-24) 7 (18, 7-33) 0.289 0,35
Early retch 5 (13, 4-12) 1 (3, 0-13) 5 (13, 4-27) 0.1 0,1
Early vomiting 4 (11, 3-25) 2 (5, 1-17) 6 (15, 6-30) 0.132 0,43
Early PONV 7 (18, 8-34) 4 (10, 3-24) 7 (18, 7-33) 0.259 0,35
Late nausea 11 (29, 15-46) 5 (13, 4-27) 14 (35, 21-52) 0.017 0,09
Late retch 8 (21, 10-37) 3 (8, 2-20) 11 (28, 15-44) 0.018 0,19
Late vomiting 5 (13, 4-12) 3 (8, 2-20) 8 (20, 9-36) 0.096 0,5
Late PONV 11 (29, 15-46) 6 (15, 6-30) 14 (35, 21-52) 0.045 0,1
All data are presented as number of patients (% of the total
and 95% CI).
Late PONV was seen in 6 patients (15%, 95% CI 6-30) treat-
ed after MPS vs. 11 patients treated after DXM (29%, 95% CI 15-
46) and 14 patients after placebo (35%, 95% CI 21-52). MPS was
superior to placebo (p 0.045). No significant differences were
shown between MPS and DXM, nor between DXM and placebo.
The relative risk reduction for late PONV for MPS is 57%
(95% CI 40-82%), the number needed to threat is 5 (95% CI 3-97).
The relative risk reduction for late PONV for DXM is 21% (95%
CI -57-57%), the number needed to threat is 17 (95% CI 4-). The
difference between MPS and DXM was not significant.
A longer duration of surgery contributed to a higher PONV
appearance. (90 (+/- 44) vs. 75 (+/- 55), p 0.0024). Duration of
anaesthesia was significantly longer in MPS group compared to
placebo (127.5 (+/- 87.5 vs. 105.0 (+/- 43.7), p 0.044). More sufen-
tanil was used in MPS group vs. placebo (27.9 (+/-10.3) vs. 23.9
(+/- 6.8), p 0.032).
The use of N2O was not significantly different between the
3 groups studied. Administration of N2O resulted in a higher
incidence of PONV (19/42 (45%, 95% CI 30-61%) vs. 23/88
(26%, 95% CI 17-37%, p = 0.044). 
Discussion
Although duration of anaesthesia was significantly longer
and significantly more sufentanil was used in the MPS group, MPS
was significantly better than placebo in the prevention of late nau-
sea, retching and PONV. As stated in literature, steroids are most-
ly effective in the prevention of late PONV.
There was a beneficial clinical effect of DXM in this population,
although not significant. Apfel found a relative risk reduction for
DXM of 26% (1), which is consistent with the 21% relative risk
reduction we found, although not significant. 
A possible explanation for not finding a significant beneficial
effect for DXM could be that our population is a population at risk
according to risk scores of Apfel and Sinclair. In a population at
risk a combination of anti emetic drugs is recommended (3).
In the majority of reports on DXM in the prevention of
PONV, 8 mg of DXM was used, although Apfel et al. proved 4 mg
of DXM to be as effective as higher doses in his 2004 article (1).
While our data were collected in 2003 and 2004, we used 8 mg of
DXM. We compared 8 mg of DXM to 40 mg of MPS to rule out a
difference in potency for the prevention of PONV. MPS was used
in much higher doses in the scarce other trials that found a benefi-
cial effect on PONV (125 mg in one report, 15 mg/kg 1 hour prior
to surgery and 0.3 mg/kg/6 hours, 4 times postoperatively in anoth-
er (2)).
In our population the duration of surgery and use of nitrous
oxide were risk factors for the occurrence of PONV. Duration of
surgery was longer in the MPS group, there was no significant dif-
ference in the use of N2O between groups.
Conclusion
This study confirms that steroids are effective in the preven-
tion of late PONV, less effective in early PONV. We showed a pos-
itive trend for DXM 8 mg vs. placebo with a NNT of 17 to prevent
late PONV, although not statistically significant. MPS 40 mg is sig-
nificantly better than placebo with a NNT of 4 to prevent late
PONV. The difference between DXM and MPS is not significant in
our study.
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Introduction
High concentrations of desflurane may irritate the air-
way and consequently increase airway resistance (1). The
aim of this study was to assess the effects of rapid increas-
es of desflurane and sevoflurane concentrations during
bolus administration on spirometry parameters in humans
during balanced anesthesia with remifentanil.
Methods
After Institutional Ethics Committee approval, written
informed consent was obtained from 30 ASA I patients
scheduled for minor non-laparoscopic surgery. Induction
was with TCI remifentanil, propofol and rocuronium
(0.9 mg.kg-1 IBW). TCI remifentanil was initiated at 4 ng/ml
and increased by 25% or decreased by 25% in order to
maintain mean arterial pressure and heart rate within 20%
of baseline during anesthesia. Patients were randomized
into 2 groups (n = 15) to receive BIS-guided desflurane or
sevoflurane targeted to maintain a BIS-value between 45
and 55. When BIS  55 for more than 30 s, an inhalation
bolus was administered. The bolus administration of desflu-
rane and sevoflurane was performed by setting the vaporiz-
er to maximum output in a fresh gas flow of 4 L/min during
15 s. Afterwards, fresh gas flow was returned to baseline
2 L/min with a 25% increased vaporizer setting. This result-
ed in 45 boli desflurane and 58 boli sevoflurane. To assess
the differences between spirometric data in a period 30 s
before and 300 s afterwards, all data were synchronized on
the start of the inhalation bolus. At every second the differ-
ence between the mean value and the 95% confidence inter-
vals (CI) were calculated (group desflurane – group sevoflu-
rane). Significance is reached when zero is not included in
the 95% confidence intervals.
Results
Patient characteristics were comparable for the two
groups. Mean end-tidal concentrations before bolus were
0.5 (0.12) MAC desflurane and 0.49 (0.18) MAC sevoflu-
rane(p = 0.46). Bolus administration resulted in mean peak
inspiratory concentrations of 10.8 (1.6) vol% desflurane and
5.4 (1.2) vol% sevoflurane (p < 0.05). Pplateau was signifi-
cantly lower during the 15 s bolus administration of desflu-
rane. Airway resistance was lower in the desflurane group
and did not differ significantly from the sevoflurane group
(Fig. 1).
The Effects of rapid increases in desflurane and sevoflurane concentrations on spirometry in humans
during balanced anesthesia with remifentanil. A. WILLEMS, L. DE BAERDEMAEKER, A. KALMAR,
M. STRUYS. Department of anesthesia, university hospital Ghent, De Pintelaan 185, 9000 Gent,
Belgium.
Discussion
Our results are in conflict with the work of Goff and
colleagues (1). When combined with remifentanil, high
inspired concentration of desflurane did not provoke bron-
choconstriction. Compared to sevoflurane, desflurane does
have bronchodilating properties (2). Repetitive increases in
desflurane concentrations might blunt airway responses (3).
Conclusions
Repetitive increases in inspiratory and end-tidal con-
centrations during inhalation boli of desflurane and sevoflu-
rane did not result in increased airway resistance.
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Fig. 1. — Time synchronised  analysis of the differences in plateau pressure and  airway resistance between groups. The difference of
the means is plotted as continous line; the differnce in upper and lower 95% CI as dotted lines. 
Significance is reached when zero is not included between the dotted lines.
